Distinguished in Polymyalgia Rheumatica

Dr. Charles M. King

Rheumatology
North Mississippi Medical Center, Inc.
408 Council Cir, 
Tupelo, MS 
 (1849.3 mi)
Accepting New Patients
Offers Telehealth
Distinguished in Polymyalgia Rheumatica
North Mississippi Medical Center, Inc.
408 Council Cir, 
Tupelo, MS 
 (1849.3 mi)
OverviewInsuranceLocationsClinical Research

Overview

Charles King is a Rheumatologist in Tupelo, Mississippi. Dr. King and is rated as a Distinguished provider by MediFind in the treatment of Polymyalgia Rheumatica. His top areas of expertise are Rheumatoid Arthritis (RA), Sjogren Syndrome, Undifferentiated Connective Tissue Disease (UCTD), and Dermatomyositis. Dr. King is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Kansas Medical College
Specialties
Rheumatology
Licenses
Internal Medicine in MS
Hospital Affiliations
North Mississippi Medical Center-Gilmore Amory
Magnolia Regional Health Center
Clay County Medical Corporation
Och Regional Medical Center
North Mississippi Medical Center
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  UnitedHealthcare

Locations

NORTH MISSISSIPPI MEDICAL CENTER, INC.
408 Council Cir, Tupelo, MS 38801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Active_not_recruiting
Publish Date: January 20, 2025
Intervention Type: Other, Biological
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Enrollment Status: Terminated
Publish Date: December 13, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 5 Less Clinical Trials

1 Total Publications

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.
Journal: Arthritis care & research
Published: April 05, 2012
Similar Doctors
Distinguished in Polymyalgia Rheumatica
Dr. Kirk C. Eddleman
Rheumatology
Distinguished in Polymyalgia Rheumatica
Dr. Kirk C. Eddleman
Rheumatology

Baptist Memorial Hospital Union County, Inc.

200 Hwy 30 W, 
New Albany, MS 
 (25.0 mi)
601-534-7631
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kirk Eddleman is a Rheumatologist in New Albany, Mississippi. Dr. Eddleman and is rated as a Distinguished provider by MediFind in the treatment of Polymyalgia Rheumatica. His top areas of expertise are Rheumatoid Arthritis (RA), Reactive Arthritis, Undifferentiated Connective Tissue Disease (UCTD), and Psoriatic Arthritis. Dr. Eddleman is currently accepting new patients.

Experienced in Polymyalgia Rheumatica
Dr. Jennifer L. Kennard
Rheumatology
Experienced in Polymyalgia Rheumatica
Dr. Jennifer L. Kennard
Rheumatology

North Mississippi Medical Center, Inc.

408 Council Cir, Suite A, 
Tupelo, MS 
662-377-1130
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jennifer Kennard is a Rheumatologist in Tupelo, Mississippi. Dr. Kennard and is rated as an Advanced provider by MediFind in the treatment of Polymyalgia Rheumatica. Her top areas of expertise are Hypersensitivity Vasculitis, Goodpasture Syndrome, Sjogren Syndrome, and Psoriatic Arthritis. Dr. Kennard is currently accepting new patients.

Experienced in Polymyalgia Rheumatica
Dr. Lauren P. Hayward
Rheumatology
Experienced in Polymyalgia Rheumatica
Dr. Lauren P. Hayward
Rheumatology

Baptist Memorial Hospital Union County, Inc.

100 Baptist Memorial Cir, Suite 204, 
Oxford, MS 
 (47.1 mi)
662-636-4333
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lauren Hayward is a Rheumatologist in Oxford, Mississippi. Dr. Hayward and is rated as an Experienced provider by MediFind in the treatment of Polymyalgia Rheumatica. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Rheumatoid Arthritis (RA), and Felty Syndrome. Dr. Hayward is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile